SecBot SecBot
8-K ·Filed Jun 12, 2026

TRLV

Trulieve Cannabis Corp.
NEUTRAL
Impact 3/10
Horizondays Processed4mo ago SEC0001754195-26-000046
8-K context-dependent: Items 5.02
Actionable Insight • Neutral

This is a routine officer departure with no financial materiality and no obvious red flags. Monitor for any subsequent 8-K naming a new President or any material changes in executive leadership structure. No immediate trading action warranted.

DirectionNeutral
Confidencehigh
Horizondays
Final — all horizons settled through T+60d
TRLV ▲ +20.10% at T+60d
NEUTRAL call +20.10% · α vs SPY +16.83% · entry $10.35 → $12.43
Entry = T+0 close
Jun 12, 2026
via day close
T+1d
-4.73%
call -4.73% · α -6.50%
$9.86
settled 4mo ago
T+5d
-2.42%
call -2.42% · α -3.09%
$10.10
settled 4mo ago
T+20d
-16.71%
call -16.71% · α -18.49%
$8.62
settled 4mo ago
T+60d
+20.10%
call +20.10% · α +16.83%
$12.43
settled 7w ago

Price Chart

Loading chart...

Executive Summary

Trulieve announced the immediate mutual separation of President Jason Pernell on June 11, 2026. He receives a modest $15,000 severance, standard COBRA coverage for up to 18 months, and accelerated vesting of unvested equity awards. No replacement has been named. This is a routine departure of a senior officer with no indication of cause-related termination, but the lack of a successor adds minor uncertainty.

Key Facts

  • President Jason Pernell separated from Trulieve effective June 11, 2026 via mutual agreement.
  • No replacement for President has been announced in this filing.
  • Pernell receives $15,000 severance payment and up to 18 months of COBRA premium coverage.
  • Pernell is subject to a 1-year lock-up restricting sale or transfer of company shares held in his name.
  • Pernell remains eligible for Q2 2026 quarterly and prorated FY2026 target performance bonuses.

Financial Impact

Severance of $15,000 plus COBRA costs (duration up to 18 months) — immaterial for a $2.2B market cap company.

cashFlow

Risk Factors

  • Lack of named successor may create short-term uncertainty in day-to-day management.
  • Possible future departure of other key executives if this signals broader management shake-up.

Market Snapshot

Exchange
OTC
Sector
Medicinal Chemicals & Botanical Products

Investment Themes

Documents Analyzed

This report is based on 4 SEC documents filed with EDGAR.

DocumentAccession Number
8-K Filing (Primary)0001754195-26-000046
Document: 0001754195-26-000046-index-headers.html0001754195-26-000046
Document: 0001754195-26-000046-index.html0001754195-26-000046
Document: 0001754195-26-000046.txt0001754195-26-000046
3 reports for TRLV
Performance horizon
Filters
Rows
Reports for TRLV — sortable, filterable
TypeNow
Aug 7, 2026
11w ago
8-K
MIXED ★ 6/10
$8.75 $12.11▲ +38.40%▲ +38.80%$10.84 (+23.89%)
Jul 2, 2026
16w ago
8-K
NEUTRAL ★ 3/10
$9.78 $8.57▼ −12.37%▼ −11.96%$10.84 (+10.84%)
Jun 12, 2026
19w ago
8-K
NEUTRAL ★ 3/10
$10.35 $8.62▼ −16.71%▼ −18.49%$10.84 (+4.73%)
Showing 3 of 3

US Market Status

Market Open — Closes in 6h 7m

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Jun 12, 2026